Compass Therapeutics (CMPX) Gets a Buy from Stifel Nicolaus
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Willey covers the Healthcare sector, focusing on stocks such as Incyte, Bicara Therapeutics Inc., and Exelixis. According to TipRanks, Willey has an average return of 2.0% and a 40.34% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Compass Therapeutics with a $13.20 average price target, which is a 396.24% upside from current levels. In a report released on July 1, Raymond James also initiated coverage with a Buy rating on the stock with a $9.00 price target.
CMPX market cap is currently $373.4M and has a P/E ratio of -6.74.
Based on the recent corporate insider activity of 8 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CMPX in relation to earlier this year. Most recently, in May 2025, Thomas Schuetz, the CEO of CMPX bought 10,000.00 shares for a total of $21,100.00.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
35 minutes ago
- Business Insider
Seek Limited (SKLTF) Receives a Buy from Macquarie
In a report released today, from Macquarie maintained a Buy rating on Seek Limited, with a price target of A$27.00. The company's shares closed last Wednesday at $15.85. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Seek Limited with a $18.06 average price target, a 13.94% upside from current levels. In a report released on July 15, Morgans also maintained a Buy rating on the stock with a A$27.20 price target. Based on Seek Limited's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $536.2 million and a net profit of $143.5 million. In comparison, last year the company earned a revenue of $596.8 million and had a net profit of $35.2 million
Business Insider
35 minutes ago
- Business Insider
UBS Sticks to Their Buy Rating for QBE Insurance Group Limited (QBEIF)
UBS analyst Kieren Chidgey maintained a Buy rating on QBE Insurance Group Limited today and set a price target of A$26.00. The company's shares closed last Wednesday at $14.83. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Chidgey covers the Financial sector, focusing on stocks such as ASX , Insurance Australia Group Limited, and QBE Insurance Group Limited. According to TipRanks, Chidgey has an average return of 9.9% and a 58.33% success rate on recommended stocks. In addition to UBS, QBE Insurance Group Limited also received a Buy from TR | OpenAI – 4o's Wesley Roofguard in a report issued on July 16. However, on July 2, Macquarie downgraded QBE Insurance Group Limited (Other OTC: QBEIF) to a Hold.
Business Insider
35 minutes ago
- Business Insider
Berenberg Bank Remains a Buy on Klepierre (ex Compagnie Fonciere Klepierre) (0F4I)
Berenberg Bank analyst Kai Klose maintained a Buy rating on Klepierre (ex Compagnie Fonciere Klepierre) on July 17 and set a price target of €37.50. The company's shares closed last Friday at €32.60. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Klose covers the Real Estate sector, focusing on stocks such as T Immobilien, Vonovia, and MERCIALYS. According to TipRanks, Klose has an average return of -3.1% and a 47.28% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Klepierre (ex Compagnie Fonciere Klepierre) with a €35.07 average price target.
